AbbVie Receivables 2010-2024 | ABBV

AbbVie receivables for the quarter ending September 30, 2024 were $11.472B, a 0.53% increase year-over-year.

  • AbbVie receivables for 2023 were $11.155B, a 0.88% decline from 2022.
  • AbbVie receivables for 2022 were $11.254B, a 12.8% increase from 2021.
  • AbbVie receivables for 2021 were $9.977B, a 13.09% increase from 2020.

AbbVie Receivables 2010-2024 | ABBV

  • AbbVie receivables for 2023 were $11.155B, a 0.88% decline from 2022.
  • AbbVie receivables for 2022 were $11.254B, a 12.8% increase from 2021.
  • AbbVie receivables for 2021 were $9.977B, a 13.09% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B